|
SF1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.00546262824264E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52070000428262E-08 |
| Normal-vs-Stage2 |
1.77987999999685E-05 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.14939999998442E-06 |
| Stage1-vs-Stage2 |
9.977600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.757200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
8.093200E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.60094201521133E-12 |
| Normal-vs-AfricanAmerican |
4.82700000004055E-06 |
| Normal-vs-Asian |
5.51399999999536E-05 |
| Caucasian-vs-AfricanAmerican |
2.073000E-01 |
| Caucasian-vs-Asian |
6.935400E-01 |
| AfricanAmerican-vs-Asian |
4.487400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.99010000093247E-08 |
| Normal-vs-Female |
6.0456972761358E-11 |
| Male-vs-Female |
1.743350E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.28259999998548E-06 |
| Normal-vs-Extreme_Weight |
1.90350000206507E-08 |
| Normal-vs-Obese |
1.23269999985354E-07 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.946600E-01 |
| Normal_Weight-vs-Obese |
4.627600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
7.768000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36149999999213E-05 |
| Normal-vs-Age(41-60Yrs) |
7.62340000015627E-08 |
| Normal-vs-Age(61-80Yrs) |
1.84820048154677E-10 |
| Normal-vs-Age(81-100Yrs) |
2.016700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.484600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.591000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.922360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.665000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.596810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.930180E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
1.319750E-01 |
| Normal-vs-Grade 3 |
1.292040E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
6.948200E-01 |
| Grade 2-vs-Grade 4 |
1.319750E-01 |
| Grade 3-vs-Grade 4 |
1.292040E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.51096970677645E-13 |
| Normal-vs-N1 |
2.941700E-03 |
| N0-vs-N1 |
5.389600E-01 |
|
|
